Novartis Balance Sheet Health
Financial Health criteria checks 4/6
Novartis has a total shareholder equity of $43.4B and total debt of $30.3B, which brings its debt-to-equity ratio to 69.8%. Its total assets and total liabilities are $103.5B and $60.1B respectively. Novartis's EBIT is $18.3B making its interest coverage ratio 57.1. It has cash and short-term investments of $13.9B.
Key information
69.8%
Debt to equity ratio
US$30.32b
Debt
| Interest coverage ratio | 57.1x |
| Cash | US$13.85b |
| Equity | US$43.44b |
| Total liabilities | US$60.08b |
| Total assets | US$103.52b |
Recent financial health updates
Recent updates
We Think Novartis' (VTX:NOVN) Robust Earnings Are Conservative
Nov 05
Investors Interested In Novartis AG's (VTX:NOVN) Earnings
Oct 21Novartis (VTX:NOVN) Has A Rock Solid Balance Sheet
Sep 04Novartis AG's (VTX:NOVN) Price In Tune With Earnings
Mar 12Novartis (VTX:NOVN) Has Announced A Dividend Of $3.30
Feb 20Is There An Opportunity With Novartis AG's (VTX:NOVN) 47% Undervaluation?
Jan 04Financial Position Analysis
Short Term Liabilities: NOVN's short term assets ($31.3B) exceed its short term liabilities ($28.1B).
Long Term Liabilities: NOVN's short term assets ($31.3B) do not cover its long term liabilities ($32.0B).
Debt to Equity History and Analysis
Debt Level: NOVN's net debt to equity ratio (37.9%) is considered satisfactory.
Reducing Debt: NOVN's debt to equity ratio has increased from 53.5% to 69.8% over the past 5 years.
Debt Coverage: NOVN's debt is well covered by operating cash flow (52.7%).
Interest Coverage: NOVN's interest payments on its debt are well covered by EBIT (57.1x coverage).